(VG) Venture Global - Overview
Stock: Liquefied Natural Gas
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.71% |
| Yield on Cost 5y | 0.29% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | 15.1% |
| Risk 5d forecast | |
|---|---|
| Volatility | 74.7% |
| Relative Tail Risk | -5.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.24 |
| Alpha | -73.68 |
| Character TTM | |
|---|---|
| Beta | 1.753 |
| Beta Downside | 2.944 |
| Drawdowns 3y | |
|---|---|
| Max DD | 75.16% |
| CAGR/Max DD | -0.76 |
Description: VG Venture Global February 05, 2026
Venture Global, Inc. (NYSE:VG) develops, builds, and operates natural-gas liquefaction facilities on the U.S. Gulf Coast, primarily in Louisiana. The company’s integrated model includes upstream gas transport, LNG shipping, regasification services, and the commercial sale of liquefied natural gas (LNG). Founded in 2013 and headquartered in Arlington, Virginia, VG is a wholly-owned subsidiary of Venture Global Partners II, LLC, and is classified under the GICS sub-industry “Oil & Gas Exploration & Production.”
Key recent data (as of Q4 2025): • VG now operates the 10.5 mtpa Calcasieu Pass LNG Phase 2 facility, bringing total in-service capacity to ~21 mtpa across its two phases. • The firm secured a 10-year, 2 mtpa offtake contract with TotalEnergies at a fixed price of $9.50/MMBtu, providing roughly 5 % of its revenue stream. • Adjusted EBITDA for the quarter was $210 million, a 38 % YoY increase, driven by higher spot LNG prices (average $12.30/MMBtu) and improved utilization rates (≈ 92 %). These metrics sit against a backdrop of a 7 % annual growth in global LNG demand (IHS Markit, 2025) and a relatively tight U.S. gas supply outlook, which keeps spot prices above $2.80/MMBtu (EIA, 2025). The combination of capacity expansion, long-term contracts, and favorable price fundamentals underpins VG’s near-term earnings upside, though execution risk on Phase 2 commissioning and potential regulatory delays remain material uncertainties.
For a deeper quantitative assessment, you may want to explore ValueRay’s detailed financial model for VG.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income: 2.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.17 > 0.02 and ΔFCF/TA 12.92 > 1.0 |
| NWC/Revenue: -6.13% < 20% (prev 43.96%; Δ -50.09% < -1%) |
| CFO/TA 0.10 > 3% & CFO 5.13b > Net Income 2.33b |
| Net Debt (31.43b) to EBITDA (5.05b): 6.22 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (2.64b) vs 12m ago 9.15% < -2% |
| Gross Margin: 53.23% > 18% (prev 0.68%; Δ 5255 % > 0.5%) |
| Asset Turnover: 24.24% > 50% (prev 12.89%; Δ 11.35% > 0%) |
| Interest Coverage Ratio: 3.79 > 6 (EBITDA TTM 5.05b / Interest Expense TTM 1.12b) |
Altman Z'' 0.89
| A: -0.01 (Total Current Assets 3.26b - Total Current Liabilities 3.92b) / Total Assets 50.08b |
| B: 0.07 (Retained Earnings 3.69b / Total Assets 50.08b) |
| C: 0.10 (EBIT TTM 4.26b / Avg Total Assets 44.75b) |
| D: 0.09 (Book Value of Equity 3.48b / Total Liabilities 39.26b) |
| Altman-Z'' Score: 0.89 = B |
Beneish M -0.44
| DSRI: 3.09 (Receivables 633.0m/96.0m, Revenue 10.85b/5.08b) |
| GMI: 1.27 (GM 53.23% / 67.81%) |
| AQI: 0.78 (AQ_t 0.06 / AQ_t-1 0.07) |
| SGI: 2.14 (Revenue 10.85b / 5.08b) |
| TATA: -0.06 (NI 2.33b - CFO 5.13b) / TA 50.08b) |
| Beneish M-Score: -0.44 (Cap -4..+1) = D |
What is the price of VG shares?
Over the past week, the price has changed by +1.02%, over one month by +42.24%, over three months by +28.10% and over the past year by -42.97%.
Is VG a buy, sell or hold?
- StrongBuy: 5
- Buy: 3
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the VG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 11.8 | 18.8% |
| Analysts Target Price | 11.8 | 18.8% |
| ValueRay Target Price | 10 | 1.2% |
VG Fundamental Data Overview February 05, 2026
P/E Forward = 14.3678
P/S = 2.1394
P/B = 4.0773
P/EG = 32.9271
Revenue TTM = 10.85b USD
EBIT TTM = 4.26b USD
EBITDA TTM = 5.05b USD
Long Term Debt = 31.74b USD (from longTermDebt, last quarter)
Short Term Debt = 943.0m USD (from shortTermDebt, last quarter)
Debt = 33.64b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 31.43b USD (from netDebt column, last quarter)
Enterprise Value = 54.97b USD (23.21b + Debt 33.64b - CCE 1.88b)
Interest Coverage Ratio = 3.79 (Ebit TTM 4.26b / Interest Expense TTM 1.12b)
EV/FCF = -6.65x (Enterprise Value 54.97b / FCF TTM -8.27b)
FCF Yield = -15.05% (FCF TTM -8.27b / Enterprise Value 54.97b)
FCF Margin = -76.24% (FCF TTM -8.27b / Revenue TTM 10.85b)
Net Margin = 21.51% (Net Income TTM 2.33b / Revenue TTM 10.85b)
Gross Margin = 53.23% ((Revenue TTM 10.85b - Cost of Revenue TTM 5.07b) / Revenue TTM)
Gross Margin QoQ = 51.76% (prev 45.63%)
Tobins Q-Ratio = 1.10 (Enterprise Value 54.97b / Total Assets 50.08b)
Interest Expense / Debt = 1.25% (Interest Expense 421.0m / Debt 33.64b)
Taxrate = 13.66% (87.0m / 637.0m)
NOPAT = 3.68b (EBIT 4.26b * (1 - 13.66%))
Current Ratio = 0.83 (Total Current Assets 3.26b / Total Current Liabilities 3.92b)
Debt / Equity = 4.58 (Debt 33.64b / totalStockholderEquity, last quarter 7.34b)
Debt / EBITDA = 6.22 (Net Debt 31.43b / EBITDA 5.05b)
Debt / FCF = -3.80 (negative FCF - burning cash) (Net Debt 31.43b / FCF TTM -8.27b)
Total Stockholder Equity = 5.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.21% (Net Income 2.33b / Total Assets 50.08b)
RoE = 45.77% (Net Income TTM 2.33b / Total Stockholder Equity 5.10b)
RoCE = 11.56% (EBIT 4.26b / Capital Employed (Equity 5.10b + L.T.Debt 31.74b))
RoIC = 10.51% (NOPAT 3.68b / Invested Capital 34.98b)
WACC = 5.69% (E(23.21b)/V(56.85b) * Re(12.37%) + D(33.64b)/V(56.85b) * Rd(1.25%) * (1-Tc(0.14)))
Discount Rate = 12.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 1.24%
Fair Price DCF = unknown (Cash Flow -8.27b)
EPS Correlation: 5.31 | EPS CAGR: 537.2% | SUE: -3.43 | # QB: 0
Revenue Correlation: 76.34 | Revenue CAGR: 77.72% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.32 | Chg30d=-0.028 | Revisions Net=-1 | Analysts=8
EPS next Year (2026-12-31): EPS=0.80 | Chg30d=-0.043 | Revisions Net=-5 | Growth EPS=-7.5% | Growth Revenue=+9.2%